These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


540 related items for PubMed ID: 21499702

  • 1. Length of prenatal exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants: effects on neonatal adaptation and psychomotor development.
    Casper RC, Gilles AA, Fleisher BE, Baran J, Enns G, Lazzeroni LC.
    Psychopharmacology (Berl); 2011 Sep; 217(2):211-9. PubMed ID: 21499702
    [Abstract] [Full Text] [Related]

  • 2. Infant developmental outcomes following prenatal exposure to antidepressants, and maternal depressed mood and positive affect.
    Hanley GE, Brain U, Oberlander TF.
    Early Hum Dev; 2013 Aug; 89(8):519-24. PubMed ID: 23384962
    [Abstract] [Full Text] [Related]

  • 3. The Roles of Maternal Depression, Serotonin Reuptake Inhibitor Treatment, and Concomitant Benzodiazepine Use on Infant Neurobehavioral Functioning Over the First Postnatal Month.
    Salisbury AL, O'Grady KE, Battle CL, Wisner KL, Anderson GM, Stroud LR, Miller-Loncar CL, Young ME, Lester BM.
    Am J Psychiatry; 2016 Feb 01; 173(2):147-57. PubMed ID: 26514656
    [Abstract] [Full Text] [Related]

  • 4. Neonatal and childhood neurodevelopmental, health and educational outcomes of children exposed to antidepressants and maternal depression during pregnancy: protocol for a retrospective population-based cohort study using linked administrative data.
    Singal D, Brownell M, Chateau D, Ruth C, Katz LY.
    BMJ Open; 2016 Nov 29; 6(11):e013293. PubMed ID: 27899401
    [Abstract] [Full Text] [Related]

  • 5. Association of Selective Serotonin Reuptake Inhibitor Exposure During Pregnancy With Speech, Scholastic, and Motor Disorders in Offspring.
    Brown AS, Gyllenberg D, Malm H, McKeague IW, Hinkka-Yli-Salomäki S, Artama M, Gissler M, Cheslack-Postava K, Weissman MM, Gingrich JA, Sourander A.
    JAMA Psychiatry; 2016 Nov 01; 73(11):1163-1170. PubMed ID: 27732704
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Selective serotonin reuptake inhibitor exposure in utero and pregnancy outcomes.
    Lund N, Pedersen LH, Henriksen TB.
    Arch Pediatr Adolesc Med; 2009 Oct 01; 163(10):949-54. PubMed ID: 19805715
    [Abstract] [Full Text] [Related]

  • 8. Pain reactivity in 2-month-old infants after prenatal and postnatal serotonin reuptake inhibitor medication exposure.
    Oberlander TF, Grunau RE, Fitzgerald C, Papsdorf M, Rurak D, Riggs W.
    Pediatrics; 2005 Feb 01; 115(2):411-25. PubMed ID: 15687451
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Alterations in Resting-State Networks Following In Utero Selective Serotonin Reuptake Inhibitor Exposure in the Neonatal Brain.
    Rotem-Kohavi N, Williams LJ, Virji-Babul N, Bjornson BH, Brain U, Werker JF, Grunau RE, Miller SP, Oberlander TF.
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2019 Jan 01; 4(1):39-49. PubMed ID: 30292808
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy.
    Casper RC, Fleisher BE, Lee-Ancajas JC, Gilles A, Gaylor E, DeBattista A, Hoyme HE.
    J Pediatr; 2003 Apr 01; 142(4):402-8. PubMed ID: 12712058
    [Abstract] [Full Text] [Related]

  • 15. Selective serotonin reuptake inhibitor (SSRI) use during pregnancy and risk of preterm birth: a systematic review and meta-analysis.
    Eke AC, Saccone G, Berghella V.
    BJOG; 2016 Nov 01; 123(12):1900-1907. PubMed ID: 27239775
    [Abstract] [Full Text] [Related]

  • 16. Does fetal exposure to SSRIs or maternal depression impact infant growth?
    Wisner KL, Bogen DL, Sit D, McShea M, Hughes C, Rizzo D, Confer A, Luther J, Eng H, Wisniewski SW.
    Am J Psychiatry; 2013 May 01; 170(5):485-93. PubMed ID: 23511234
    [Abstract] [Full Text] [Related]

  • 17. Intra-uterine exposure to selective serotonin reuptake inhibitors (SSRIs), maternal psychopathology, and neurodevelopment at age 2.5years - Results from the prospective cohort SMOK study.
    van der Veere CN, de Vries NKS, van Braeckel KNJA, Bos AF.
    Early Hum Dev; 2020 Aug 01; 147():105075. PubMed ID: 32504880
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. SSRI antidepressants: altered psychomotor development following exposure in utero?
    Prescrire Int; 2013 Feb 01; 22(135):43-4. PubMed ID: 23444502
    [Abstract] [Full Text] [Related]

  • 20. Prenatal SSRI exposure: Effects on later child development.
    Hermansen TK, Melinder A.
    Child Neuropsychol; 2015 Feb 01; 21(5):543-69. PubMed ID: 25089614
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 27.